Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

iodine I 131 tositumomab

A monoclonal antibody directed against the CD20 protein expressed on the surface of B-lymphocytes and radiolabeled with the radioisotope iodine I 131 with potential antineoplastic activity. Iodine I 131 tositumomab binds to and selectively delivers cyctotoxic radiation to CD20-expressing B-lymphocytes, thereby minimizing systemic radiotoxicity.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	131-I-anti-B1 monoclonal antibody I 131 monoclonal antibody anti-B1 I 131 tositumomab iodine I 131 MOAB anti-B1 iodine I 131 monoclonal antibody anti-B1 iodine-131 anti-B1 antibody iodine-131 anti-CD20 monoclonal antibody iodine-131 tositumomab tositumomab I-131
Abbreviation:	I131-MOAB-B1
NSC code:	715813

iodine I 131 tositumomab

Search NCI's Drug Dictionary